BFO
ZBH icon

Boston Family Office’s Zimmer Biomet ZBH Stock Holding History

Boston Family Office’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,883
Closed -$313K – 281
2024
Q2 		$313K Hold
2,883
– – 0.02% 219
2024
Q1 		$380K Buy
2,883
+18
+0.6% +$2.25K 0.03% 208
2023
Q4 		$349K Buy
2,865
+124
+5% +$13.8K 0.03% 214
2023
Q3 		$308K Buy
2,741
+50
+2% +$6.35K 0.03% 219
2023
Q2 		$392K Sell
2,691
-89
-3% -$12.1K 0.03% 211
2023
Q1 		$360K Buy
2,780
+129
+5% +$16.2K 0.03% 217
2022
Q4 		$338K Buy
2,651
+545
+26% +$63.2K 0.03% 222
2022
Q3 		$220K Buy
+2,106
New +$231K 0.02% 253
2022
Q2 		– Sell
-1,618
Closed -$207K – 289
2022
Q1 		$207K Sell
1,618
-52
-3% -$6.27K 0.01% 282
2021
Q4 		$206K Buy
1,670
+151
+10% +$19.8K 0.01% 277
2021
Q3 		$216K Buy
1,519
+28
+2% +$4.12K 0.02% 269
2021
Q2 		$233K Buy
1,491
+133
+10% +$21.5K 0.02% 256
2021
Q1 		$223K Sell
1,358
-54
-4% -$8.37K 0.02% 255
2020
Q4 		$211K Buy
+1,412
New +$199K 0.02% 252

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Boston Family Office's ZBH Position: Q3 2024 in Review

Boston Family Office sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 2,883 shares — an estimated $313K sold.

Boston Family Office first reported a position in ZBH in Q4 2020 and held it in 14 quarters. The position peaked at $392K in Q2 2023. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Boston Family Office reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • Boston Family Office sold 2,883 Zimmer Biomet shares in Q3 2024, an estimated $313K.
  • Boston Family Office first reported a position in Zimmer Biomet in Q4 2020 and held it in 14 quarters.
  • Boston Family Office's Zimmer Biomet position peaked at $392K in Q2 2023.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Boston Family Office's 13F filing for Q3 2024, filed 13 Nov 2024.